Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Notch alters VEGF responsiveness in human and murine endothelial cells by direct regulation of VEGFR-3 expression
Carrie J. Shawber, Yasuhiro Funahashi, Esther Francisco, Marina Vorontchikhina, Yukari Kitamura, Stephanie A. Stowell, Valeriya Borisenko, Nikki Feirt, Simona Podgrabinska, Kazuko Shiraishi, Kallayanee Chawengsaksophak, Janet Rossant, Domenico Accili, Mihaela Skobe, Jan Kitajewski
Carrie J. Shawber, Yasuhiro Funahashi, Esther Francisco, Marina Vorontchikhina, Yukari Kitamura, Stephanie A. Stowell, Valeriya Borisenko, Nikki Feirt, Simona Podgrabinska, Kazuko Shiraishi, Kallayanee Chawengsaksophak, Janet Rossant, Domenico Accili, Mihaela Skobe, Jan Kitajewski
View: Text | PDF
Research Article Vascular biology

Notch alters VEGF responsiveness in human and murine endothelial cells by direct regulation of VEGFR-3 expression

  • Text
  • PDF
Abstract

The Notch family of cell surface receptors and its ligands are highly conserved proteins that regulate cell fate determination, including those involved in mammalian vascular development. We report that Notch induces VEGFR-3 expression in vitro in human endothelial cells and in vivo in mice. In vitro, Notch in complex with the DNA-binding protein CBF-1/suppressor of hairless/Lag1 (CSL) bound the VEGFR-3 promoter and transactivated VEGFR-3 specifically in endothelial cells. Through induction of VEGFR-3, Notch increased endothelial cell responsiveness to VEGF-C, promoting endothelial cell survival and morphological changes. In vivo, VEGFR-3 was upregulated in endothelial cells with active Notch signaling. Mice heterozygous for null alleles of both Notch1 and VEGFR-3 had significantly reduced viability and displayed midgestational vascular patterning defects analogous to Notch1 nullizygous embryos. We found that Notch1 and Notch4 were expressed in normal and tumor lymphatic endothelial cells and that Notch1 was activated in lymphatic endothelium of invasive mammary micropapillary carcinomas. These results demonstrate that Notch1 and VEGFR-3 interact genetically, that Notch directly induces VEGFR-3 in blood endothelial cells to regulate vascular development, and that Notch may function in tumor lymphangiogenesis.

Authors

Carrie J. Shawber, Yasuhiro Funahashi, Esther Francisco, Marina Vorontchikhina, Yukari Kitamura, Stephanie A. Stowell, Valeriya Borisenko, Nikki Feirt, Simona Podgrabinska, Kazuko Shiraishi, Kallayanee Chawengsaksophak, Janet Rossant, Domenico Accili, Mihaela Skobe, Jan Kitajewski

×

Figure 1

Notch upregulates VEGFR-3 in cultured endothelial cells.

Options: View larger image (or click on image) Download as PowerPoint
Notch upregulates VEGFR-3 in cultured endothelial cells.
(A) Diagram of ...
(A) Diagram of Notch protein structure. N1IC encodes the cytoplasmic domain of Notch1. N4/int-3 encodes 30 amino acids upstream of the transmembrane domain, the transmembrane domain, and the cytoplasmic domain of Notch4 fused to a HA tag. (B) Western blot analysis of Ad-LacZ or N4/int-3 endothelial cells using anti-HA antibody. (C) Activation of a CSL luciferase reporter in endothelial cells expressing N4/int-3, represented as fold induction in Ad–N4/int-3 cells relative to Ad-LacZ. Data are an average of 3 independent experiments. (D) qRT-PCR of Tie and VEGFRs in Ad-infected endothelial cells. Values were normalized to β-actin qRT-PCR. Data of 3 independent qRT-PCR analyses are represented as fold induction in Ad–N4/int-3 cells relative to Ad-LacZ. (E) Western blot analysis of cell surface proteins isolated from Ad-LacZ and Ad–N4/int-3 endothelial cells immunoblotted with anti–VEGFR-3 antibody and total cell lysates immunoblotted with anti–α-tubulin antibody. (F) Western blot analysis of cell surface proteins (CSPs) isolated from Ad-LacZ–, Ad–N4/int-3–, and Ad-N1IC–infected endothelial cells immunoblotted with antibodies against VEGFR-3 and α-tubulin. Total cell lysates (TCLs) immunoblotted with antibodies against the HA epitope of N4/int-3 (12CA5), N1IC, and α-tubulin. (G and H) VEGFR-3, Hey1, and Hey2 qRT-PCR of Jagged1/Notch4 (J1/N4) or Dll4/Notch4 (Dll4/N4) HUVEC cocultures, respectively. Values were normalized by β-actin qRT-PCR and are presented as relative values. (I) VEGFR-2 and VEGFR-3 FACS of Ad-LacZ, Ad-N1IC, and Ad–N4/int-3 BECs.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts